Story: CoraMetix
Episode: 5
Presenter: Christina Morrissy
Air Date: 5th May 2024

Developing next-generation polymeric heart valves using advanced 3D printing technologies.

• CoraMetix is a spin out company from ground-breaking research at The University of Western Australia (UWA) and the Harry Perkins Institute of Medical Research. CHF products are Australian designed with large component parts manufactured in Australia. 
• CoraMetix is developing a 3D printed valve to tackle a growing heart health issue, aortic stenosis, a condition that narrows heart valves, affecting millions of people globally.
• Aortic stenosis, or a narrowing of the aortic valve opening, restricts the blood flow from the left ventricle to the aorta, leading to increased angina and breathlessness. 
• In Australia, around 1 in 8 people require replacement valves. If left untreated, severe aortic stenosis can lead to heart failure and up to 50% of patients do not survive beyond 3 years. 
• CoraMetix aims to deliver a next-generation heart valve that provides best-in-class performance and durability. By using a 3D-printing technique called Melt Electro Writing (MEW), they have designed and tested a patented biopolymer 3D-printed heart valve scaffold which mimics the mechanical properties of native human valves. 

For more information, head to:
www.corametix.com